networks_in_health_beverly_stainsby

Networks in Health appoints Beverly Stainsby

June 13, 2011
Sales and Marketing appointment, sales and marketing

Beverly Stainsby has joined Networks in Health, an alliance of online doctors’ communities, as international account director. She joins from …

European pharma’s compliance challenge

June 13, 2011
Sales and Marketing global regulatory landscape, regulatory affairs, regulatory compliance

Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …

GlaxoSmithKline

GSK’s epilepsy treatment Potiga wins US approval

June 13, 2011
Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy

The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …

Takeda Actos (pioglitazone)

France pulls Takeda diabetes drugs after cancer fears

June 13, 2011
Sales and Marketing Actos, Competact, EMA, Takeda

The French medicines agency has moved to prevent two Takeda diabetes drugs from being prescribed after fears they could increase …

New Priorclave Autoclave Bound to be First

June 10, 2011
Manufacturing and Production

Although it provides for increased loading, the combination of forced air cooling reduces cycle times and automatic timed free-steaming improves …

Digital Pharma: European doctors turn to the social web

June 10, 2011
Medical Communications Digital Pharma blog, digital doctors, social media

European GPs are making increasing use of the social web and new research has shown Wikipedia to be the most …

EMA's Guido Rasi

Rasi nominated to be EMA chief

June 10, 2011
Research and Development, Sales and Marketing EMA, Guido Rasi, Thomas Lönngren

The European Medicines Agency has nominated Italy’s Guido Rasi to be its next head, after a protracted and messy search. …

GPs warn the government: don’t cut NHS off at the legs

June 10, 2011
Health and Social Care Bill, NHS reforms

The government’s beleaguered reform programme could amputate whole parts of the NHS and must be heavily amended if not fully …

EU red tape blamed for decline in UK clinical trials

June 10, 2011
Research and Development UK clinical research, clinical trials

Medical and pharma groups have blamed European Union red tape for the decline in the UK as a location for …

ApotheCom ScopeMedical expands team

June 10, 2011
Medical Communications ApotheCom ScopeMedical, medical communications

Kent-based healthcare communications agency ApotheCom ScopeMedical has expanded its team, appointing new medical and project management staff. Joining the Huntsworth …

Eurocom wins dermal filler account

June 10, 2011
Medical Communications Eurocom, medical communications

Eurocom Healthcare Communications has been appointed to manage marketing communications for Ellansé, a novel family of dermal fillers. The London-based …

Red Door appoints Claire Pay

June 10, 2011
Medical Communications appointment, medical communications

Red Door Communications has bolstered its consumer heath team with the addition of Claire Pay, who joins the healthcare agency …

Validus Pharmaceuticals Deploys Veeva iRep to US Salesforce

June 9, 2011

PLEASANTON, CA — June 9, 2011

lilly_andrew_hotchkiss

Lilly promotes Andrew Hotchkiss

June 9, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Lilly has appointed Andrew Hotchkiss president of its operations in Australia, Canada and Europe. Andrew has been with the company …

Daiichi Sankyo: Europe poses huge challenge for pharma

June 9, 2011
Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing

Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …

NICE thumbs up for Allergan’s Ozurdex

June 9, 2011
Sales and Marketing Allergan, BRVO, CVRO, NICE, Ozurdex

In draft guidance NICE has recommended the use of Allergan’s eye treatment Ozurdex.NICE’s final decision on Ozurdex (dexamethasone) is expected …

Merck Serono headquarters

Merck Serono signs neurodegenerative collaboration

June 9, 2011
Research and Development Affectis Pharmaceuticals, Merck Serono

Merck Serono has struck a deal with biotech firm Affectis Pharmaceuticals to develop oral neurodegeneration compounds. The companies will commercialise …

ABPI's Richard Barker

The Pharmafocus Interview: Richard Barker

June 9, 2011
Research and Development, Sales and Marketing ABPI, Dr Richard Barker, vita

Dr Richard Barker has been at the helm of the UK pharma industry for over six years, but is now …

Price transparency and timing at risk, warns EFPIA

June 9, 2011
Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing

Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …

Free webinar on An Introduction to Scientific Advice in the EU

June 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Following the success of the recent pharmacovigilance webinars delivered, Wainwright Associates are offering a webinar on An Introduction to Scientific …

The Gateway to Local Adoption Series

Latest content